[This Week's IPO] June First Week Bookbuilding and Subscription Schedule

In the first week of this month (June), Innosimulation, Quratis, and Proteomtec will conduct demand forecasting for institutional investors.

◆Innosimulation= Innosimulation develops virtual and augmented reality solutions through core XR simulation technology based on digital twins, supplying smart mobility simulators and XR virtual training systems to the market.

The total number of shares offered is 900,000, with a desired offering price range of 13,000 to 15,000 KRW per share, and a total offering amount of 11.7 billion to 13.5 billion KRW. The offering price will be finalized through institutional demand forecasting on May 30-31, followed by a general subscription on June 7 and 8. The lead underwriter is Hana Securities.

◆Quratis= Quratis is a company specializing in immune-related vaccine development, also engaged in contract manufacturing (CMO) and contract development and manufacturing (CDMO) businesses. Its main development products currently are the adult and adolescent tuberculosis vaccine ‘QTP101’ and the next-generation mRNA COVID-19 vaccine ‘QTP104’.

The total number of shares offered is 3.5 million, with a desired offering price per share of 6,500 to 8,000 KRW. Aiming to enter the KOSDAQ in June, institutional demand forecasting will be conducted from May 30 to 31 to finalize the offering price, followed by general subscriptions on June 5 and 7. Daishin Securities and ShinYoung Securities jointly serve as lead underwriters.

◆Proteomtec= Proteomtec is a specialized company that develops and manufactures in vitro diagnostic medical devices. It has succeeded in developing the world’s largest allergy multiplex diagnostic kit, ‘Protia Allergy Q-128M,’ and possesses proprietary immunodiagnostic technology. Unlike existing diagnostic products, Protia Allergy Q-128M applies parallel line-type array manufacturing technology, enabling simultaneous testing of a total of 118 allergens with a minimal amount of serum.

The total number of shares offered is 2 million, with a desired offering price range of 5,400 to 6,600 KRW, amounting to 10.8 billion KRW. Institutional demand forecasting will be conducted on May 31 and June 1, followed by general subscriptions on June 7 and 8. The lead underwriter is Kiwoom Securities.